These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35852878)

  • 41. [Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].
    Bershteĭn LM; Semiglazov VF
    Vopr Onkol; 2011; 57(5):559-66. PubMed ID: 22238924
    [No Abstract]   [Full Text] [Related]  

  • 42. Metformin for cancer prevention.
    Yang Y
    Front Med; 2011 Jun; 5(2):115-7. PubMed ID: 21695613
    [No Abstract]   [Full Text] [Related]  

  • 43. Metformin.
    Bailey CJ; Turner RC
    N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
    [No Abstract]   [Full Text] [Related]  

  • 44. Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.
    Berstein LM; Iyevleva AG; Vasilyev D; Poroshina TE; Imyanitov EN
    Cell Cycle; 2013 Dec; 12(23):3681-8. PubMed ID: 24145224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
    Vona-Davis L; Rose DP
    Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Summaries for patients. Metformin for patients with type 2 diabetes mellitus.
    Ann Intern Med; 2002 Jul; 137(1):I50. PubMed ID: 12093266
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of metformin in type II diabetes.
    Epstein S
    Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
    [No Abstract]   [Full Text] [Related]  

  • 48. Metformin: a biguanide.
    Tanja JJ; Langlass TM
    Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of type 2 diabetes with metformin].
    Amouyal C; Andreelli F
    Rev Prat; 2015 Dec; 65(10):1245-9. PubMed ID: 26979012
    [No Abstract]   [Full Text] [Related]  

  • 51. [Biguanide].
    Tanaka Y
    Nihon Rinsho; 2012 May; 70 Suppl 3():647-51. PubMed ID: 22768592
    [No Abstract]   [Full Text] [Related]  

  • 52. Metformin in breast cancer: time for action.
    Goodwin PJ; Ligibel JA; Stambolic V
    J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
    [No Abstract]   [Full Text] [Related]  

  • 53. Metformin: evidence-based versus rational pharmacotherapy.
    Smits P; Tack CJ
    Neth J Med; 2002 Jul; 60(6):228-30. PubMed ID: 12365465
    [No Abstract]   [Full Text] [Related]  

  • 54. [Role of metformin in gynaecology and obstetrics].
    Scheen AJ; Philips JC; Kridelka F
    Rev Med Liege; 2018 Dec; 73(12):597-602. PubMed ID: 30570229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mystery of metformin.
    Spiering MJ
    J Biol Chem; 2019 Apr; 294(17):6689-6691. PubMed ID: 31028160
    [No Abstract]   [Full Text] [Related]  

  • 56. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
    Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
    PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin: intrinsic vasculoprotective properties.
    Wiernsperger NF
    Diabetes Technol Ther; 2000; 2(2):259-72. PubMed ID: 11469268
    [No Abstract]   [Full Text] [Related]  

  • 58. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes.
    Behrouzi B; Zokaasadi M; Mohagheghi MA; Emami AH; Sadighi S
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):611-616. PubMed ID: 33639681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy).
    Viswanathan V; Chacko PT; Lavanya M; Tilak P
    J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022
    [No Abstract]   [Full Text] [Related]  

  • 60. Metformin and ovarian cancer survival: is there a rational warrant for belief?
    Mormile R
    Arch Gynecol Obstet; 2019 Oct; 300(4):797-798. PubMed ID: 31346700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.